AAAAAA
Results:
1-12
|
Results: 12
Authors:
Jost, E
Michaux, L
Vanden Abeele, M
Boland, B
Latinne, D
Godfraind, C
Scheiff, JM
Vaerman, JL
Lecouvet, F
Ferrant, A
Citation: E. Jost et al., Complex karyotype and absence of mutation in the c-kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia and brain damage, ANN HEMATOL, 80(5), 2001, pp. 302-307
Authors:
Deneys, V
Michaux, L
Leveugle, P
Mazzon, AM
Gillis, E
Ferrant, A
Scheiff, JM
De Bruyere, M
Citation: V. Deneys et al., Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expression, LEUKEMIA, 15(9), 2001, pp. 1458-1465
Authors:
Layios, N
Van den Neste, E
Jost, E
Deneys, V
Scheiff, JM
Ferrant, A
Citation: N. Layios et al., Remission of severe cold agglutinin disease after Rituximab therapy, LEUKEMIA, 15(1), 2001, pp. 187-188
Authors:
Belacel, N
Vincke, P
Scheiff, JM
Boulassel, MR
Citation: N. Belacel et al., Acute leukemia diagnosis aid using multicriteria fuzzy assignment methodology, COMPUT M PR, 64(2), 2001, pp. 145-151
Authors:
Abena, PA
Mathieux, VG
Scheiff, JM
Michaux, LM
Vandercam, BC
Citation: Pa. Abena et al., Linezolid and reversible myelosuppression, J AM MED A, 286(16), 2001, pp. 1973
Authors:
Louviaux, I
Van Den Neste, E
Scheiff, JM
Michaux, L
Straetmans, N
Ferrant, A
Citation: I. Louviaux et al., Digital clubbing in a patient with progressive mantle cell lymphoma, ANN HEMATOL, 78(1), 1999, pp. 29-31
Authors:
Gala, JL
Guiot, Y
Delannoy, A
Scheiff, JM
Philippe, M
Martiat, P
Citation: Jl. Gala et al., Use of image analysis and immunostaining of bone marrow trephine biopsy specimens to quantify residual disease in patients with B-cell chronic lymphocytic leukemia, MOD PATHOL, 12(4), 1999, pp. 391-399
Authors:
Van Den Neste, E
Bontemps, F
Delacauw, A
Cardoen, S
Louviaux, I
Scheiff, JM
Gillis, E
Leveugle, P
Deneys, V
Ferrant, A
Van den Berghe, G
Citation: E. Van Den Neste et al., Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2 '-deoxyadenosine, LEUKEMIA, 13(6), 1999, pp. 918-925
Authors:
Goasguen, JE
Zandecki, M
Mathiot, C
Scheiff, JM
Bizet, M
Ly-Sunnaram, B
Grosbois, B
Monconduit, M
Michaux, JL
Facon, T
Citation: Je. Goasguen et al., Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology, LEUK RES, 23(12), 1999, pp. 1133-1140
Authors:
Gala, JL
Scheiff, JM
Citation: Jl. Gala et Jm. Scheiff, L26 (CD20) staining of Bouin fixed bone marrow biopsies - Author's reply, J CLIN PATH, 52(12), 1999, pp. 931-932
Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2 '-deoxyadenosine
Authors:
Van Den Neste, E
Louviaux, I
Michaux, JL
Delannoy, A
Michaux, L
Hagemeijer, A
Scheiff, JM
Bosly, A
Straetmans, N
Ferrant, A
Citation: E. Van Den Neste et al., Myelodysplastic syndrome with monosomy 5 and/or 7 following therapy with 2-chloro-2 '-deoxyadenosine, BR J HAEM, 105(1), 1999, pp. 268-270
Authors:
Lecouvet, FE
Vande Berg, BC
Michaux, L
Scheiff, JM
Malghem, J
Jamart, J
Maldague, BE
Michaux, JL
Ferrant, A
Citation: Fe. Lecouvet et al., Chronic lymphocytic leukemia: Changes in bone marrow composition and distribution assessed with quantitative MRI, J MAGN R I, 8(3), 1998, pp. 733-739
Risultati:
1-12
|